Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Fall_Line_Capital
|
| gptkbp:acquisitionYear |
2023
|
| gptkbp:CEO |
gptkb:Andrey_Zarur
|
| gptkbp:developedBy |
RNA-based products
|
| gptkbp:focusesOn |
human health
agricultural solutions RNA research |
| gptkbp:foundedYear |
2008
|
| gptkbp:founder |
gptkb:John_Gill
gptkb:Andrey_Zarur |
| gptkbp:headquartersLocation |
gptkb:Medford,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Greenlight Biosciences
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:notableProduct |
mRNA vaccines
RNA-based crop protection |
| gptkbp:publiclyTraded |
yes
|
| gptkbp:stockSymbol |
gptkb:GRNA
|
| gptkbp:website |
https://www.greenlightbiosciences.com/
|
| gptkbp:bfsParent |
gptkb:Breakthrough_Energy_Ventures
|
| gptkbp:bfsLayer |
5
|